CLINICAL_TRIALS
trial_result
· 2008-06-03
Clinical Trial Update: Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis [Phase 3]
Summary
A Phase 3 trial evaluating ASF1057 for seborrheic dermatitis has completed, assessing efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astion Pharma A/S | Conditions: Seborrheic Dermatitis | Phase 3 | Status: COMPLETED